Safety and Tolerability of SPD485 in Children Aged 6-12 Diagnosed With ADHD and Previously Participated in MTS Trials
Conditions
- Attention Deficit Disorder With Hyperactivity
Interventions
- DRUG: Methylphenidate Transdermal System
Sponsor
Noven Therapeutics
Collaborators